Bausch & Lomb Corp Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Bausch & Lomb Corp (BLCO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $4.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-07-29
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was $2.00M.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was $2.00M.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was $23.00M.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was -$23.00M, a 2400.00% decline year-over-year.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$27.00M.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$9.00M, a 550.00% decline from fiscal 2023.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $2.00M.
- Bausch & Lomb Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was -$5.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $4.00M 10-Q · filed 2026-07-29 | $27.00M derived: sum of 3 quarters · filed 2026-07-29 | $4.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $2.00M 10-Q · filed 2026-04-29 | $25.00M derived: sum of 2 quarters · filed 2026-04-29 | $2.00M derived: sum of 3 quarters · filed 2026-04-29 | -$16.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | -$18.00M derived: sum of 3 quarters · filed 2026-07-29 | -$27.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$41.00M derived: sum of 2 quarters · filed 2026-07-29 | -$50.00M 10-Q · filed 2025-10-29 | -$61.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$27.00M 10-Q · filed 2026-07-29 | -$38.00M derived: sum of 3 quarters · filed 2026-07-29 | -$37.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$9.00M 10-Q · filed 2026-04-29 | -$20.00M derived: sum of 2 quarters · filed 2026-04-29 | -$19.00M derived: sum of 3 quarters · filed 2026-04-29 | -$19.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$10.00M derived: sum of 2 quarters · filed 2026-02-18 | -$10.00M derived: sum of 3 quarters · filed 2026-02-18 | -$9.00M 10-K · filed 2026-02-18 |
| 2024-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.00M derived: sum of 2 quarters · filed 2025-10-29 | $2.00M 10-Q · filed 2025-10-29 | $4.00M derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.00M 10-Q · filed 2025-07-30 | $3.00M derived: sum of 3 quarters · filed 2025-07-30 | $2.00M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | $1.00M 10-Q · filed 2025-04-30 | $3.00M derived: sum of 2 quarters · filed 2025-04-30 | $2.00M derived: sum of 3 quarters · filed 2025-04-30 | $3.00M derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.00M derived: sum of 2 quarters · filed 2025-02-19 | $2.00M derived: sum of 3 quarters · filed 2025-02-19 | $2.00M 10-K · filed 2025-02-19 |
| 2023-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.00M 10-Q · filed 2024-08-01 | $1.00M derived: sum of 3 quarters · filed 2024-08-01 | $1.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2024-05-01 | $0.00 derived: sum of 3 quarters · filed 2024-05-01 | -$5.00M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 derived: sum of 2 quarters · filed 2024-02-21 | -$5.00M derived: sum of 3 quarters · filed 2024-02-21 | -$5.00M 10-K · filed 2024-02-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$5.00M derived: sum of 2 quarters · filed 2023-11-01 | -$5.00M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$5.00M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |